Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
European Journal of Pediatrics|April 15, 2022
Co-administration of drugs with parenteral nutrition in the neonatal intensive care unit-physical compatibility between three componentsNiklas Nilsson, Ingebjørg Storesund, Ingunn Tho, et al.Paediatric Anaesthesia|November 7, 2022
Exploring a case of incompatibility in a complex regimen containing Plasma-Lyte 148 in the pediatric intensive careNiklas Nilsson, Vivian Nguyen, Katerina Nezvalova-Henriksen, et al.Acta Paediatrica (Oslo, Norway : 1992)|August 26, 2022
Frequently acquired drugs in neonatal intensive care and their physical compatibilityKaterina Nezvalova-Henriksen, Tone Huseby Holm, Niklas Nilsson, et al.Pharmaceutics|July 26, 2020
Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive CareKaterina Nezvalova-Henriksen, Niklas Nilsson, Camilla Tomine Østerberg, et al.Pharmaceutics|September 27, 2025
Strategies for Assessing Physical Compatibility of Calcium Folinate with Bicarbonate During Methotrexate Rescue Therapy in Pediatric Patients with Acute Lymphoblastic LeukemiaKaveh Teimori, Bjarke Strøm Larsen, Mathias Buaas Austli, et al.European Journal of Haematology|August 21, 2025
Three-Month Posttransplant Lipidomic Profile Reflects Acute GVHD but Not Chronic GVHD Risk in Allogeneic Stem Cell RecipientsTor Henrik Anderson Tvedt, Christian Qvigstad, Katerina Nezvalova-Henriksen, et al.Molecular Pharmaceutics|May 11, 2023
Co-administration of Intravenous Drugs: Rapidly Troubleshooting the Solid Form Composition of a Precipitate in a Multi-drug Mixture Using On-Site Raman SpectroscopyNiklas Nilsson, Katerina Nezvalova-Henriksen, Johan P Bøtker, et al.Communications Medicine|November 12, 2024
The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysisThale D J Hovdun Patrick-Brown, Andreas Barratt-Due, Marius Trøseid, et al.Bone Marrow Transplantation|August 1, 2023
Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working GroupKaterina Nezvalova-Henriksen, Claudia Langebrake, Tiene Bauters, et al.Bone Marrow Transplantation|September 13, 2024
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)Vera Domingos, Katerina Nezvalova-Henriksen, Adrin Dadkhah, et al.Pageof 2